“If scientific and technological information is developed and used by the Federal Government, it should ordinarily be made available to the public,” according to a new memorandum on “Scientific Integrity” that was issued by President Obama on March 9.
Another presidential memorandum promises to limit the use of “presidential signing statements” that raise constitutional objections to provisions of enacted legislation. President Obama said that whenever he issues such a signing statement, he will “make clear the nature and basis of the constitutional objection.” By contrast, many signing statements that were produced by the Bush White House employed broad, formulaic objections whose scope and precise application were unclear.
To secure the U.S. bio-infrastructure, maintain global leadership in biotechnology, and safeguard American citizens from emerging threats to their privacy, the federal government must modernize its approach to human genetic and biological data.
To ensure an energy transition that brings broad based economic development, participation, and direct benefits to communities, we need federal policy that helps shape markets. Unfortunately, there is a large gap in understanding of how to leverage federal policy making to support access to capital and credit.
From use to testing to deployment, the scaffolding for responsible integration of AI into high-risk use cases is just not there.
OPM’s new HR 2.0 initiative is entering hostile terrain. Those who have followed federal HR modernization for years desperately want this effort to succeed.